6 By ONA_Eloise March 14, 2018 No Comments Share Tweet Pinterest LinkedIn Tumblr Email + Share. Twitter Facebook Pinterest LinkedIn Tumblr Email
ASCO 2026: Selpercatinib shows decrease in risk of disease recurrence or death as adjuvant therapy for early-stage RET fusion-positive NSCLC June 4, 2026 0
ASCO 2026: Digital symptom monitoring with nurse support helps maintain quality of life in advanced cancer June 4, 2026 0
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma June 4, 2026 0